Präoperative Blutungsanamnese
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bach A (2001) Anforderungen an das System OP – Organisatorische Voraussetzungen/Kosten. Zentralbl Chir 126: 336–340
Barber A, Green D, Galluzzo T et al. (1985) The bleeding time as a preoperative screening test. Am J Med 78: 761–764
Beran M, Stigendal L, Petruson B (1987) Haemostatic disorders in habitual nose-bleeders. J Laryngol Otol 101: 1020–1028
Borzotta AP, Keeling MM (1984) Value of the preoperative history as an indicator of hemostatic disorders. Ann Surg 200: 648–652
Dzik WH (2004) Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 3: 324–330
Eberl W, Wendt I, Schroeder HG (2005) Präperatives Screening auf Gerinnungsstörungen vor Adenotomie und Tonsillektomie. Klin Padiatr 217: 20–24
Edlund M, Blomback M, Schoultz B von et al. (1996) On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 53: 234–238
Eika C, Havig O, Godal HC (1978) The value of preoperative haemostatic screening. Scand J Haematol 21: 349–354
George JN, Shattil SJ (1991) The clinical importance of acquired abnormalities of platelet function. N Engl J Med 324: 27–39
Houry S, Georgeac C, Hay JM et al. (1995) A prospective multicenter evaluation of preoperative hemostatic screening tests. The French Associations for Surgical Research. Am J Surg 170: 19–23
Kadir RA, Economides DL, Sabin CA et al. (1998) Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 351: 485–489
Kaplan EB, Sheiner LB, Boeckmann AJ et al. (1985) The usefulness of preoperative laboratory screening. JAMA 253: 3576–3581
Kitchens CS (2005) To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 3: 2607–2611
Koscielny J, Kiesewetter H, Tempelhoff GF von (2006) More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 4: 1426–1427; discussion 1428–1434
Koscielny J, Ziemer S, Radtke H et al. (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 195–204
Koscielny J, Tempelhoff GF von, Ziemer S et al. (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155–166
Lee A, Chui PT, Aun CS et al. (2006) Incidence and risk of adverse perioperative events among surgical patients taking traditional Chinese herbal medicines. Anesthesiology 105: 454–461
Lillicrap D, Nair SC, Srivastava A et al. (2006) Laboratory issues in bleeding disorders. Haemophilia 12 [Suppl 3]: 68–75
Macpherson CR, Jacobs P, Dent DM (1993) Abnormal peri-operative haemorrhage in asymptomatic patients is not predicted by laboratory testing. S Afr Med J 83: 106–108
Rodeghiero F, Castaman G (2001) Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment. Best Pract Res Clin Haematol 14: 321–335
Rohrer MJ, Michelotti MC, Nahrwold DL (1988) A prospective evaluation of the efficacy of preoperative coagulation testing. Ann Surg 208: 554–557
Sadler JE (2003) Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 101: 2089–2093
Silwer J (1973) Von Willebrand’s disease in Sweden. Acta Paediatr Scand Suppl 238: 1–159
Sramek A, Eikenboom JC, Briet E et al. (1995) Usefulness of patient interview in bleeding disorders. Arch Intern Med 155: 1409–1415
Strauß J, Becke K, Schmidt J (2006) Auf die Anamnese kommt es an. Normale Laborparameter vor HNO-Operationen im Kindesalter schließen Gerinnungsstörungen nicht aus. Dtsch Arztebl 103: A1948
Velanovich V (1991) The value of routine preoperative laboratory testing in predicting postoperative complications: a multivariate analysis. Surgery 109: 236–243